seed
Stage
2
Investors
About
DotLab develops DotEndo, a non-invasive blood test that identifies active endometriosis across all stages by measuring biomarkers and applying biostatistics, aiming to reduce diagnostic delays.
Explore DotLab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.